Utah Retirement Systems increased its holdings in Catalent Inc (NYSE:CTLT) by 9.4% in the 3rd quarter, HoldingsChannel reports. The fund owned 26,800 shares of the company’s stock after buying an additional 2,300 shares during the quarter. Utah Retirement Systems’ holdings in Catalent were worth $1,220,000 as of its most recent SEC filing.
Other institutional investors have also modified their holdings of the company. JPMorgan Chase & Co. increased its stake in Catalent by 29.5% during the 3rd quarter. JPMorgan Chase & Co. now owns 7,976,203 shares of the company’s stock valued at $363,316,000 after purchasing an additional 1,819,020 shares in the last quarter. Millennium Management LLC increased its stake in Catalent by 4,244.2% during the 2nd quarter. Millennium Management LLC now owns 1,200,267 shares of the company’s stock valued at $50,279,000 after purchasing an additional 1,172,638 shares in the last quarter. William Blair Investment Management LLC increased its stake in Catalent by 26.7% during the 3rd quarter. William Blair Investment Management LLC now owns 4,364,177 shares of the company’s stock valued at $198,788,000 after purchasing an additional 920,869 shares in the last quarter. Janus Henderson Group PLC increased its stake in Catalent by 13.0% during the 3rd quarter. Janus Henderson Group PLC now owns 7,234,661 shares of the company’s stock valued at $329,539,000 after purchasing an additional 833,924 shares in the last quarter. Finally, BlackRock Inc. increased its stake in Catalent by 7.0% during the 3rd quarter. BlackRock Inc. now owns 12,628,951 shares of the company’s stock valued at $575,248,000 after purchasing an additional 822,258 shares in the last quarter. Institutional investors own 96.77% of the company’s stock.
Shares of NYSE CTLT opened at $36.32 on Friday. The company has a current ratio of 2.05, a quick ratio of 1.61 and a debt-to-equity ratio of 1.44. The stock has a market cap of $5.42 billion, a PE ratio of 22.75, a P/E/G ratio of 2.33 and a beta of 1.44. Catalent Inc has a 52-week low of $34.24 and a 52-week high of $47.87.
Catalent (NYSE:CTLT) last announced its quarterly earnings results on Tuesday, November 6th. The company reported $0.28 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.24 by $0.04. The firm had revenue of $551.80 million for the quarter, compared to the consensus estimate of $582.44 million. Catalent had a net margin of 2.65% and a return on equity of 19.13%. The business’s quarterly revenue was up 1.5% compared to the same quarter last year. During the same quarter last year, the firm posted $0.21 EPS. On average, equities research analysts forecast that Catalent Inc will post 1.63 earnings per share for the current fiscal year.
A number of analysts have weighed in on CTLT shares. JPMorgan Chase & Co. raised their price objective on shares of Catalent from $50.00 to $55.00 and gave the company an “overweight” rating in a research note on Wednesday, August 29th. Zacks Investment Research lowered shares of Catalent from a “hold” rating to a “sell” rating in a research note on Monday, September 3rd. UBS Group started coverage on shares of Catalent in a research note on Tuesday, October 9th. They set a “neutral” rating and a $48.00 price objective for the company. ValuEngine lowered shares of Catalent from a “buy” rating to a “hold” rating in a research note on Tuesday, November 6th. Finally, First Analysis upgraded shares of Catalent from a “neutral” rating to an “outperform” rating and reduced their price objective for the company from $47.00 to $43.00 in a research note on Wednesday, November 7th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and ten have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $48.00.
In other news, insider Barry Littlejohns sold 47,265 shares of the firm’s stock in a transaction dated Monday, October 15th. The shares were sold at an average price of $41.64, for a total transaction of $1,968,114.60. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP Lance Miyamoto sold 6,525 shares of the firm’s stock in a transaction dated Tuesday, October 16th. The shares were sold at an average price of $42.50, for a total transaction of $277,312.50. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 184,335 shares of company stock worth $8,161,727. Insiders own 1.40% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Utah Retirement Systems Raises Position in Catalent Inc (CTLT)” was originally published by Stock Observer and is the property of of Stock Observer. If you are viewing this news story on another site, it was illegally stolen and republished in violation of United States & international trademark and copyright laws. The original version of this news story can be viewed at https://www.thestockobserver.com/2018/12/08/utah-retirement-systems-raises-position-in-catalent-inc-ctlt.html.
Catalent Company Profile
Catalent, Inc provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products worldwide. It operates through four segments: Softgel Technologies, Biologics and Specialty Drug Delivery, Oral Drug Delivery, and Clinical Supply Services. The Softgel Technologies segment formulates, develops, and manufactures prescription and consumer soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations.
Further Reading: How accurate is the Rule of 72?
Want to see what other hedge funds are holding CTLT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Catalent Inc (NYSE:CTLT).
Receive News & Ratings for Catalent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catalent and related companies with MarketBeat.com's FREE daily email newsletter.